You are here

Zurzuvae

5 Reasons Biogen’s Shares Have Dropped 36% in 2024

BioSpace

Thu, 11/14/24 - 11:19 am

Biogen, Sage admit a defeat in major depression

BioPharma Dive

Wed, 10/30/24 - 08:43 pm

SAGE Therapeutics

postpartum depression

major depressive disorder

Sage’s recent trial failure adds pressure to its two-drug Biogen collab

Pharma Voice

Mon, 07/29/24 - 10:29 am

SAGE Therapeutics

clinical trials

essential tremor

postpartum depression

Biogen sees ‘encouraging’ trends for postpartum depression drug

BioPharma Dive

Wed, 04/24/24 - 09:18 pm

postpartum depression

Sage offers encouraging details on launch of new postpartum depression pill

BioPharma Dive

Wed, 02/14/24 - 06:42 pm

SAGE Therapeutics

postpartum depression

Biogen-Sage Therapeutics postpartum depression pill priced at $15,900

Reuters

Tue, 11/7/23 - 09:55 am

SAGE Therapeutics

postpartum depression

Biogen, Sage's postpartum depression approval overshadowed by larger rejection

Fierce Pharma

Mon, 08/7/23 - 12:01 pm

SAGE Therapeutics

postpartum depression

major depressive disorder

FDA Approves Biogen, Sage’s Zurzuvae as First Pill for Postpartum Depression

BioSpace

Sun, 08/6/23 - 09:39 pm

SAGE Therapeutics

postpartum depression

major depressive disorder